Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Kam AYF"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cheung CHY; Blood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Cheng CK; Blood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Leung KT; Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong SAR, China., Zhang C; Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong SAR, China., Ho CY; Blood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Luo X; Blood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Kam AYF; Blood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Xia T; Blood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Wan TSK; Blood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Pitts HA; Blood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Chan NPH; Blood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Cheung JS; Blood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Wong RSM; Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong SAR, China., Zhang XB; Department of Medicine, Loma Linda University, Loma Linda, California., Ng MHL; Blood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China.
Publikováno v:
Blood advances [Blood Adv] 2024 May 14; Vol. 8 (9), pp. 2217-2234.
Autor:
Kam AYF; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Piryani SO; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Lee CL; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina.; Duke Cancer Institute, Duke University, Durham, North Carolina., Rizzieri DA; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Duke Cancer Institute, Duke University, Durham, North Carolina., Spector NL; Duke Cancer Institute, Duke University, Durham, North Carolina.; Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina., Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Duke Cancer Institute, Duke University, Durham, North Carolina., Doan PL; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina. Phuong.Doan@duke.edu.; Duke Cancer Institute, Duke University, Durham, North Carolina.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2021 May; Vol. 19 (5), pp. 886-899. Date of Electronic Publication: 2021 Jan 29.
Autor:
Piryani SO; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA., Kam AYF; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA., Vu UT; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA., Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA; Duke Cancer Institute, Duke University, 595 LaSalle Street, DUMC 103866, Durham, NC 27710, USA., Doan PL; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA; Duke Cancer Institute, Duke University, 595 LaSalle Street, DUMC 103866, Durham, NC 27710, USA. Electronic address: phuong.doan@duke.edu.
Publikováno v:
Stem cell reports [Stem Cell Reports] 2019 Jul 09; Vol. 13 (1), pp. 76-90. Date of Electronic Publication: 2019 May 30.
Autor:
Kam AYF; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina., Piryani SO; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina., McCall CM; Department of Pathology, Duke University, Durham, North Carolina., Park HS; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina., Rizzieri DA; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina.; Duke Cancer Institute, Duke University, Durham, North Carolina., Doan PL; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina. phuong.doan@duke.edu.; Duke Cancer Institute, Duke University, Durham, North Carolina.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Jul 01; Vol. 25 (13), pp. 4155-4167. Date of Electronic Publication: 2019 Apr 05.
Autor:
Piryani SO; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina., Jiao Y; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina., Kam AYF; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina., Liu Y; Department of Biomedical Engineering, Duke University, Durham, North Carolina; Department of Biomedical Engineering Chemistry, Duke University, Durham, North Carolina., Vo-Dinh T; Department of Biomedical Engineering, Duke University, Durham, North Carolina; Department of Biomedical Engineering Chemistry, Duke University, Durham, North Carolina., Chen BJ; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina; Duke Cancer Institute, Duke University, Durham, North Carolina., Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina; Duke Cancer Institute, Duke University, Durham, North Carolina., Doan PL; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina; Duke Cancer Institute, Duke University, Durham, North Carolina. Electronic address: phuong.doan@duke.edu.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 Jun 01; Vol. 104 (2), pp. 291-301. Date of Electronic Publication: 2019 Feb 11.